New England Journal of Medicine Publishes Efficacy and Safety Data for GARDASIL® in Males
WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Merck (known as MSD outside the United States and Canada) announced today that data from the pivotal Phase III study with GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] in males were published in the February 3 issue of the New England Journal of Medicine (NEJM). In this study, GARDASIL was 89 percent …
Gonorrhea Facts
Tags: cancer · cervical · genital warts fact sheet · genital warts facts · genital warts facts and statistics · genital warts facts men · hpv genital warts facts · infection · treatment · vaccinationNo Comments
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.